20 reasons why patients should see more of you.

21 Reasons Why Visiting the Doctor More Often is So Important It’s impossible to know when you’re going to get sick or injured, no matter how cautious you are. But, there are plenty of health problems you can prevent, detect or improve by visiting your doctor on more regularly. How Often People Visit Doctors Most people don’t visit the doctor nearly as often as they should. According to a Household Economic Studies report put out in 2013, the average number of doctor visits annually by a working-age adult in 2010 was 3.9. This is down from the average of 4.8 visits […]

Should You “Fire” a Patient Who Won’t Cooperate with Their Treatment Plan?

Determining whether or not to “fire” a patient is a notoriously difficult decision for doctors in every type of practice. You are so busy, patients who don’t seem to care about their own well-being can feel frustrating and a waste of your time. Even though it’s generally considered a last-resort option, there are times when informing a noncompliant patient that they should seek care elsewhere is ultimately the best choice for both you and the patient. Why Noncompliance Is a Big Deal

When Money Isn’t Enough: What Do You Really Want from Your Medical Career?

You are done with Med School, Residency, and perhaps have established yourself in private practice or with a really great healthcare institution. Despite that, you’re still on the treadmill of loan balances, patient loads, and long hours, and trying to have some semblance of a life. It’s a LOT. But, money makes the world go around, right? Maybe it’s time to determine what is most important to you in a compensation package.  Loans, Loans, Go Away… The pervasive assumption that the average doctor compensation is more than adequate has made it difficult for physicians and other medical professionals to get a leg […]

Why Physician Burnout Affects Patient Care

Like an engine with a bad wire that isn’t able to fire on all cylinders, physician burnout has the potential to drag down the performance of even the most committed and energized health care professionals. Consequences of burnout may ripple outward to include critical aspects of patient care. The Lancet, JAMA, the National Institutes of Health and the Mayo Clinic, among others have reported the importance of a work life balance, research important to both physicians and patients alike.  Cartoon credit to Rob Rogers, 2012, reprinted from The Chest Journal  What Is Physician Burnout? Physicians, like people in other demanding professions, are susceptible to a […]

In Case You Missed It: USPSTF Recommendations for Screening of latent tuberculosis infection

It has been estimated that up to 5% of the population of the United States between 18 and 65 years of age have latent tuberculosis infections (LTBI), and approximately 10,000 new cases of active tuberculosis were reported in the US in 2015, according to a recent article reported in the Journal of the American Medical Association. Approximately 30% of individuals exposed to tuberculosis will develop LTBI. Left untreated, 5% to 10% of those with LTBI will develop active tuberculosis. According to the United States Preventive Services Task Force (USPSTF), screening tools for LTBI exist, including the tuberculin skin test (TST) […]

#MDLinkUp Twitter Chat Summary: Flu Vaccine

Since our first live #MDLinkUp Twitter Chat went so well we decided to hold a second session on flu vaccines at @MDLinx on September 22, 2016. With the flu season quickly approaching, many patients have similar questions for their physicians. We wanted to address some of them by going straight to the medical community. For those who aren’t aware, a Twitter Chat is a live, public Twitter conversation centered on one unique topic and a related hashtag. This hashtag allows users to follow the discussion and participate in the conversation. Using the #MDLinkUp hashtag we facilitated a conversation with our followers to tackle some basic questions about […]

In Case You Missed It: Early vs Delayed Use of Antiretroviral Therapy to Reduce Transmission of HIV-1 in Serodiscordant Couples

A recent study published in the New England Journal of Medicine reported that in 2014 there were more than 2 million new HIV-1 infections worldwide, most of which occurred via sexual transmission. Effective HIV-1 prevention strategies are required to reduce the risk of viral transmission from infected persons to their sexual partners. Other studies involving serodiscordant couples have suggested that antiretroviral therapy (ART) in those with HIV-1 infection reduces the risk of sexual transmission. The HIV Prevention Trials Network (HPTN) 052 trial, led by Myron S. Cohen, MD, was designed to determine the efficacy of antiretroviral therapy (ART) on preventing genetically-linked […]

#MDLinkUp Twitter Chat Summary: The Zika Virus

Recently, @MDLinx kicked off our inaugural #MDLinkUp Twitter Chat. For those who aren’t aware, a Twitter Chat is a live, public Twitter conversation centered on one unique topic and a related hashtag. This hashtag allows users to follow the discussion and participate in the conversation. Our first chat was focused on the Zika Virus, a topic that has been trending recently in the medical community and beyond. Using the #MDLinkUp hashtag we facilitated a conversation with our followers to tackle some basic questions about Zika, taking into account the latest research and prevention methodologies. Take a look at some of […]

In Case You Missed It: Daratumumab demonstrates significantly longer progression-free survival in multiple myeloma

Recently, results of a phase 3 trial performed by Antonio Palumbo, MD and other CASTOR investigators was published in the New England Journal of Medicine (N Engl J Med. 2016; 375:754-766) demonstrating the efficacy of daratumumab (16 mg/kg), an anti-CD38 monoclonal antibody, with bortezomib (1.3 mg/m2) plus dexamethasone (20 mg) in treatment of patients with relapses or relapsed and refractory multiple myeloma (n=498). Specifically, the progression-free survival (60.7% vs 26.9%), overall response (82.9% vs 63.2%), very good partial response or better (59.2% vs 29.1%), and complete response (19.2% vs 9.0%) was superior in the daratumumab with bortezomib plus dexamethasone group than […]

MDLinx Conference Coverage – July 2016

The MDLinx editors covered 4 interesting medical conferences during the month of July with a focus on dermatology, AIDS, ENT, cancer, and gastrointestinal cancer. Some of the highlights follow. As reported at the ESMO 18th World Congress on Gastrointestinal Cancer held in Barcelona, Spain, June 29–July 2 July, anti-IL-1α antibody is effective in patients with metastatic colorectal cancer who have failed standard therapy (oxaliplatin and irinotecan). Patients treated with anti-IL-1α monoclonal antibody (n=207) had a 33% treatment responsecompared with 19% in patients treated with placebo. There was also a 26% relative risk reduction in adverse events. Use of a free […]